TODAY'S NEWS
A new retrospective study examined outcomes for pa...
Through a systematic review of published studies, ...
On June 17, the U.S. Food and Drug Administra...
In the phase III QuANTUM-R trial reported in The L...
As reported at the 2019 ASCO Annual Meeting and in...
More News From Today 
EDITORIALS & COMMENTARY
A number of immune checkpoint inhibitors (ICIs) have been approved by the FDA...
ES is a 41-year-old transgender male who presented to medical oncology as a referral...
In secondary data analysis (SDA) studies, investigators use data collected by other researchers...
Rucaparib and niraparib are two of the newest U.S. Food and Drug Administration–approved PARP inhibitors...
Chimeric antigen receptor (CAR) T-cell therapy represents an exciting innovation in the treatment of cancer...
More Editorials & Commentary 
